Assi, R., Kantarjian, H., Kadia, T. M., Pemmaraju, N., Jabbour, E., Jain, N., . . . Borthakur, G. (2018). Final Results of a Phase 2, Open-Label Study of Indisulam, Idarubicin and Cytarabine in Patients with Relapsed or Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome. Cancer.
Styl cytowania ChicagoAssi, Rita, et al. "Final Results of a Phase 2, Open-Label Study of Indisulam, Idarubicin and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome." Cancer 2018.
Styl cytowania MLAAssi, Rita, et al. "Final Results of a Phase 2, Open-Label Study of Indisulam, Idarubicin and Cytarabine in Patients With Relapsed or Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome." Cancer 2018.